Our dream is becoming a reality: revolutionizing Alzheimer's diagnostics

Our dream is becoming a reality. When we founded PraanaTech, we had a clear vision: to revolutionize the Alzheimer's disease diagnostics scene. Not in the incremental, "10% better" sense that characterizes so much of the medical device industry. In the transformative sense — changing who has access to the most powerful diagnostic tools available, where those tools can be deployed, and what the experience of early detection can mean for patients and families who have long been told that nothing could be done until the disease was already well advanced.

The foundation of that vision is PET imaging technology. Specifically, the idea that the extraordinary diagnostic power of amyloid PET — which can detect the pathological hallmarks of Alzheimer's disease years or even decades before symptoms appear — does not need to be confined to the world's leading academic medical centers. It can be made available in community hospitals, outpatient clinics, and diagnostic imaging centers that serve the neighborhoods where real patients live. Doing that requires rethinking the technology from the ground up: smaller systems, more efficient detectors, lower operational complexity, and a cost structure that makes broad deployment economically viable. That is the engineering challenge we have dedicated ourselves to at PraanaTech, and we are ready to show the world what we have built.

We are ready to revolutionize the Alzheimer's disease diagnostics scene because the moment demands it. The arrival of disease-modifying therapies — drugs that can genuinely slow the progression of Alzheimer's when given early enough — has transformed the urgency of early diagnosis from a scientific aspiration to a clinical imperative. Every month that passes without a confirmed diagnosis is a month of potentially effective treatment lost. Every patient who cannot access a PET scan because there is no scanner near them or they cannot afford it is a patient who may miss the window for intervention. We exist to close those gaps — and we are just getting started.